Weight Loss Drugs Market to reach USD 45.35 Billion by 2032 and grow at a CAGR of 43.73%
The growing obesity rates are the main factor driving the weight loss drugs market, largely boosting its growth. As of 2022, more than 650 million adults around the world were obese and since 1975 global prevalence has nearly tripled according to the World Health Organization (WHO) According to data from the Centers for Disease Control and Prevention (CDC), 42.4 percent of American adults are affected by obesity, highlighting a critical need for efficacious weight management solutions that work fast. Hence the increase in demand for weight loss medications to assist with this rising obesity rate as people and healthcare systems struggle against this epidemic.